New president for Robert Bosch Healthcare, Inc. as of January 2011 Dr. Jasper zu Putlitz (47) joins U.S. telemedicine company

· Dr. zu Putlitz previously partner at McKinsey & Company in Germany

· Derek Newell, current president of Robert Bosch Healthcare, to leave at the end of 2010

Stuttgart, Germany/Palo Alto, California: As of January 1, 2011, Dr. Jasper zu Putlitz (47) will be assuming the position of president of Robert Bosch Healthcare, Inc., a Bosch subsidiary headquartered in Palo Alto, California. Zu Putlitz’s predecessor, Derek Newell, has chosen to leave Bosch Healthcare at the end of 2010. Bosch, a supplier of technology and services, sees telemedicine as a strategic business field that should be expanded in light of demographic change.

Zu Putlitz: a medical doctor with international experience
Zu Putlitz was born in Heidelberg, Germany. He worked for the consulting firm McKinsey as a partner and a member of the German management for the past five years. There, zu Putlitz was responsible for key areas, with a focus on health and logistics, as well as human resources and organization. Before he began consulting work in 1999, zu Putlitz, who has an MD degree, spent seven years working as a doctor at the Munich, Zurich, Freiburg, and Harvard university hospitals.

"We are very pleased to welcome Dr. zu Putlitz to our company. He brings with him expertise both as a healthcare specialist with international experience, and as a corporate-strategy and process-optimization professional,” said Dr. Siegfried Dais, the deputy chairman of the Bosch board of management whose responsibilities include the growth areas innovative software systems, photovoltaics, and healthcare. Dais thanked Derek Newell for the major contribution he had made to ensuring positive business developments at Robert Bosch Healthcare, Inc.

Looking ahead to his new position, zu Putlitz said: “Telemedicine will increasingly shape healthcare in the future. I greatly look forward to collaborating with the healthcare team to take advantage of the potential for growth in this sector. In this way, we can give an added boost to the Bosch Group’s strategy of focused diversification.”

Robert Bosch Healthcare Inc. is a leading provider of innovative telehealth systems. Bosch’s product spectrum ranges from patient terminals to comprehensive evaluation software allowing healthcare professionals to efficiently evaluate the data coming from the patient terminals and other connected devices. Bosch Telehealth strives to improve diagnosis and treatment through systematic patient monitoring and involvement. The result is that health professionals are able to provide a higher quality of care providing for patients with chronic conditions, patients lead happier and healthier lives, and the cost of healthcare is reduced for funders. Robert Bosch Healthcare, Inc. is a fully-owned subsidiary of the Bosch Group.

For more information, go to www.bosch-telehealth.com.

The Bosch Group is a leading global supplier of technology and services. In the areas of automotive and industrial technology, consumer goods, and building technology, some 275,000 associates generated sales of 38.2 billion euros in fiscal 2009. The Bosch Group comprises Robert Bosch GmbH and its more than 300 subsidiaries and regional companies in over 60 countries. If its sales and service partners are included, then Bosch is repre-sented in roughly 150 countries. This worldwide development, manufacturing, and sales network is the foundation for growth. Each year, Bosch spends more than 3.5 billion euros for research and development, and applies for some 3,800 patents worldwide. With all its products and services, Bosch enhances the quality of life by providing solutions which are both innovative and beneficial.

The company was set up in Stuttgart in 1886 by Robert Bosch (1861–1942) as “Workshop for Precision Mechanics and Electrical Engineering.” The special ownership structure of Robert Bosch GmbH guarantees the entrepreneurial freedom of the Bosch Group, making it possible for the company to plan over the long term and to undertake significant up-front investments in the safeguarding of its future. Ninety-two percent of the share capital of Robert Bosch GmbH is held by Robert Bosch Stiftung GmbH, a charitable foundation. The majority of voting rights are held by Robert Bosch Industrietreuhand KG, an industrial trust. The entrepreneurial ownership functions are carried out by the trust. The remaining shares are held by the Bosch family and by Robert Bosch GmbH.

Additional information can be accessed at www.bosch.com.